CYP19A1 and brain ischemia: In addition, utilizing the FBN-ARO-KO and GFAP-ARO-KO mice in disorders other than global cerebral ischemia could also help to further delineate the role of ADE2 and NDE2 in various aspects of these other neurological disorders.